Fast Growing Stocks With High Insider Ownership

Results

181

12 new

Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.

181 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	ALM	US$18.28	11.7%	326.1%	US$5.3b	US$25.93	68.0	37.1%	n/a	Materials
	PGEN	US$7.17	9.5%	80.2%	US$2.6b	US$14.50	29.9	55.4%	n/a	Pharmaceuticals & Biotech
	HIMX	US$13.44	-12.8%	73.0%	US$2.4b	US$30.20	66.5	70.2%	2.8%	Semiconductors
	DAVE	US$354.79	3.9%	79.2%	US$4.5b	US$436.58	20.3	23.0%	n/a	Diversified Financials
	KRMN	US$51.37	-16.9%	-3.1%	US$7.1b	US$87.10	183.1	54.0%	n/a	Capital Goods
	UPST	US$29.89	0.5%	-56.8%	US$2.9b	US$40.60	48.2	65.6%	n/a	Diversified Financials
	ALAB	US$277.53	-13.3%	59.4%	US$49.4b	US$389.95	130.3	33.2%	n/a	Semiconductors
	UXIN	US$1.14	0.9%	-72.7%	US$264.0m	US$4.00	0.4	69.4%	n/a	Retail
	CG	US$49.14	1.2%	-22.8%	US$17.6b	US$58.18	48.1	20.5%	2.8%	Diversified Financials
	HNGE	US$89.98	2.4%	63.4%	US$7.1b	US$106.47	67.7	27.1%	n/a	Healthcare
	EROC	US$13.12	-24.6%	n/a	US$3.9b	US$22.88	3.9	57.2%	0%	Capital Goods
	FSUN	US$40.56	-1.0%	8.2%	US$1.9b	US$45.75	1.0	97.4%	n/a	Banks
	AIRJ New	US$5.01	-13.8%	4.8%	US$368.2m	US$9.55	1.5	71.1%	n/a	Capital Goods
	OSTX	US$1.55	5.4%	-29.2%	US$73.3m	US$8.92	-1.8	56.3%	n/a	Pharmaceuticals & Biotech
	ABEO	US$6.06	2.0%	-13.6%	US$348.3m	US$18.86	13.6	70.1%	n/a	Pharmaceuticals & Biotech
	CBUS	US$1.73	3.6%	31.1%	US$129.9m	US$14.33	30.4	63.8%	n/a	Pharmaceuticals & Biotech
	INMB	US$2.36	10.8%	5.4%	US$64.4m	US$7.00	3.2	43.4%	n/a	Pharmaceuticals & Biotech
	FIGR	US$38.64	8.1%	n/a	US$8.8b	US$51.57	45.3	32.8%	n/a	Diversified Financials
	METC	US$12.43	1.6%	-49.3%	US$695.7m	US$18.88	1.5	109.4%	0%	Materials
	KVHI	US$7.49	-8.1%	35.2%	US$139.7m	n/a	1.1	167.0%	n/a	Tech
	WRD	US$5.97	-1.8%	-37.8%	US$2.1b	US$13.75	15.9	39.1%	n/a	Automobiles
	GUER New	US$4.19	4.9%	251.8%	US$42.6m	US$8.00	1.6	170.0%	n/a	Semiconductors
	QTI	US$3.31	22.6%	-52.6%	US$42.6m	US$11.60	1.8	114.0%	n/a	Healthcare
	TEM	US$66.17	28.1%	-12.8%	US$13.1b	US$63.36	8.3	45.0%	n/a	Pharmaceuticals & Biotech

Page 1 of 6